相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
Ulrike Hoeckendorf et al.
CANCER CELL (2016)
K45Amutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo
B. Shutinoski et al.
CELL DEATH AND DIFFERENTIATION (2016)
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
K. Newton et al.
CELL DEATH AND DIFFERENTIATION (2016)
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
Lena Seifert et al.
NATURE (2016)
Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis
Boris Strilic et al.
NATURE (2016)
VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
Xiujuan Li et al.
NATURE COMMUNICATIONS (2016)
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo et al.
CELL RESEARCH (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
Absence of RIPK3 predicts necroptosis resistance in malignant melanoma
P. Geserick et al.
CELL DEATH & DISEASE (2015)
RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation
Susanne V. Schmidt et al.
ONCOTARGET (2015)
Receptor-Interacting Protein Kinase 3 Deficiency Delays Cutaneous Wound Healing
Andrew Godwin et al.
PLOS ONE (2015)
Necroptosis Is Active in Children With Inflammatory Bowel Disease and Contributes to Heighten Intestinal Inflammation
Maria Pierdomenico et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1-and RIPK3-dependent manner
W. Wei-Lynn Wong et al.
BLOOD (2014)
RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction
Mark Luedde et al.
CARDIOVASCULAR RESEARCH (2014)
RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
James A. Rickard et al.
CELL (2014)
RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
Christopher P. Dillon et al.
CELL (2014)
The Necroptosis Adaptor RIPK3 Promotes Injury-Induced Cytokine Expression and Tissue Repair
Kenta Moriwaki et al.
IMMUNITY (2014)
Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
Scott B. Berger et al.
JOURNAL OF IMMUNOLOGY (2014)
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
Pratyusha Mandal et al.
MOLECULAR CELL (2014)
Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death
Joanne M. Hildebrand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition
William J. Kaiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
Kim Newton et al.
SCIENCE (2014)
Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons
Brian J. Wainger et al.
CELL REPORTS (2014)
Vascular permeability changes involved in tumor metastasis
Jonathan Garcia-Roman et al.
CANCER LETTERS (2013)
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
James M. Murphy et al.
IMMUNITY (2013)
Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
William J. Kaiser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death
Dimitry Ofengeim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
RIP3 Inhibits Inflammatory Hepatocarcinogenesis but Promotes Cholestasis by Controlling Caspase-8-and JNK-Dependent Compensatory Cell Proliferation
Mihael Vucur et al.
CELL REPORTS (2013)
Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway
Monika Julia Wolf et al.
CANCER CELL (2012)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd
Zuyue Sun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
YoungSik Cho et al.
CELL (2009)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
Characterizing DNA methylation patterns in pancreatic cancer genome
Aik Choon Tan et al.
MOLECULAR ONCOLOGY (2009)
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Duan-Wu Zhang et al.
SCIENCE (2009)
The FGF system has a key role in regulating vascular integrity
Masahiro Murakami et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Src kinase phosphorylates caspase-8 on Tyr380:: a novel mechanism of apoptosis suppression
Silvia Cursi et al.
EMBO JOURNAL (2006)
Activation of p38 has opposing effects on the proliferation and migration of endothelial cells
ME McMullen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Kinase RIP3 is dispensable for normal NF-KBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4
K Newton et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
N Holler et al.
NATURE IMMUNOLOGY (2000)